Mutation of tumor protein 53 (TP53) is the most frequent genetic alteration in bladder cancer, which results in transcriptional activation, senescence, apoptosis, and changes in metabolism,[4, 5] promoting tumor progression (Figure1a). This evidence concerns the gene TP53 and urinary bladder cancer.